Laboratory diagnosis of Clostridium difficile

The Lancet Infectious Diseases

Volumn 13, Issue 11, 2013, Pages 909-911

  Goldenberg, Simon D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; BACTERIAL TRANSMISSION; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CYTOTOXIN ASSAY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIARRHEA; ENZYME IMMUNOASSAY; FALSE NEGATIVE RESULT; GLUTAMATE DEHYDROGENASE ASSAY; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; LABORATORY DIAGNOSIS; LETTER; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

CLOSTRIDIUM DIFFICILE; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; MALE;

EID: 84885955558     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(13)70222-6     Document Type: Letter

References (14)

1. Chassany O, Michaux A, Bergmann JF Drug induced diarrhea. Drug Saf 2000, 22:53-72.
2. Polage CR, Solnick JV, Coehn SH Nosocomial diarrhea: evaluation and treatment of causes other than Clostridium difficile. Clin Infect Dis 2012, 55:982-989.
3. Saade E, Deshpande A, Kundrapu S, et al. Appropriateness of empiric therapy in patients with suspected Clostridium difficile infection. Curr Med Res Opin 2013, 29:985-988.
4. Sunkesula V, Kundrapu S, Jury LA, et al. Potential for transmission of spores by patients awaiting laboratory testing to confirm suspected Clostridium difficile infection. Infect Control Hosp Epidemiol 2013, 34:306-308.
5. Goldenberg SD, French GL Diagnostic testing for Clostridium difficile: a comprehensive survey of laboratories in England. J Hosp Infect 2011, 79:4-7.
6. Goldenberg SD, Price NM, Tucker D, Wade P, French GL Mandatory reporting and improvements in diagnosing Clostridium difficile infection: an incompatible dichotomy?. J Infect 2011, 62:363-370.
7. Planche TD, Davies KA, Coen PG, et al. Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic evaluation study of C difficile infection. Lancet Infect Dis 2013, published online Sept 3. http://dx.doi.org/10.1016/S1473-3099(13)70200-7.
8. Polage CR, Chin DL, Leslie JL, et al. Outcomes in patients tested for Clostridium difficile toxins. Diagn Microbiol Infect Dis 2013, 74:369-373.
9. Baker I, Leeming JP, Reynolds R, Ibrahim I, Darley E Clinical relevance of a positive molecular test in the diagnosis of Clostridium difficile infection. J Hosp Infect 2013, 84:311-315.
10. Longtin Y, Trottier S, Brochu G, et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis 2013, 56:67-73.
11. Walker AS, Eyre DW, Wyllie DH, et al. Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing. Plos Med 2012, 9:e1001172.
12. Curry SR, Muto CA, Schlackman JL, et al. Use of MLVA genotyping to determine the role of asymptomatic carriers in C. difficile transmission. Clin Infect Dis 2013, published online July 23. 10.1093/cid/cit475.
13. Bartsch SM, Curry SR, Harrison LH, Lee BY The potential economic value of screening hospital admissions for Clostridium difficile. Eur J Clin Microbiol Infect Dis 2012, 31:3163-3171.
14. Goldenberg SD, Volpe H, French GL Clinical negligence, litigation and healthcare-associated infections. J Hosp Infect 2012, 81:156-162.